$CBIO

$13.67▲ +0.9% YTD

9 SEC 13D/G filings tracked · Last updated Nov 2, 2026

Filing History

News

CBIO ▲ +0.9% - Crescent Biopharma, Inc.

CP $13.67▲ +0.9%Nov 2, 2026 · ThinkSabio Blog

$CBIO - Crescent Biopharma to Present at November Investor Conferences…

SEC 13D/G

CBIO - Crescent Biopharma, Inc. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks Simplified

$13.27▲ 19.77%Oct 27, 2026 · ThinkSabio Blog

$CBIO SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #CBIO Crescent Biopharma, Inc. : $13.27 Sector: Healthcare | YTD…

News

CBIO ▼ -0.7% - Crescent Biopharma, Inc.

CP $12.48▲ -0.7%Oct 15, 2026 · ThinkSabio Blog

$CBIO - Crescent Biopharma Announces Clinical Pipeline Momentum, including Enrolling Patients in Standard of Care Chemotherapy Combination Cohorts of…

News

CBIO ▼ -2.5% - Crescent Biopharma, Inc.

CP $13.57▲ -2.5%Oct 6, 2026 · ThinkSabio Blog

$CBIO - Crescent Biopharma Announces Grants of Inducement Awards…

News

CBIO ▲ +2.0% - Crescent Biopharma, Inc.

CP $14.61▲ +2.0%Oct 5, 2026 · ThinkSabio Blog

$CBIO - Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of S…

News

CBIO ▼ -1.9% - Crescent Biopharma, Inc.

CP $13.99▲ -1.9%Sep 25, 2026 · ThinkSabio Blog

$CBIO - Crescent Biopharma Announces Grants of Inducement Awards…

News

CBIO ▼ -2.2% - Crescent Biopharma, Inc.

CP $19.99▲ -2.2%Sep 9, 2026 · ThinkSabio Blog

$CBIO - Crescent Biopharma Announces Grants of Inducement Awards…

News

CBIO ▲ +0.2% - Crescent Biopharma, Inc.

CP $18.54▲ +0.2%Sep 3, 2026 · ThinkSabio Blog

$CBIO - Crescent Biopharma to Present at September Investor Conferences…

SEC 13D/G

$CBIO SEC Filing Update (20-JUL-2026) | ThinkSabio - Stocks Simplified

$15.32▲ 38.27%Jul 20, 2026 · ThinkSabio Blog

$CBIO SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #CBIO : $15.32 Sector: Healthcare | YTD: 🔼+ 38.27% The SEC discl…